Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale

15th Jan 2025 08:43

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More

Pfizer to more than halve Haleon holding in GBP2.57 billion sale

14th Jan 2025 17:24

(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorgan Securities on Tuesday. Read More

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

13th Jan 2025 09:08

(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfolio in gastrointestinal cancers". Read More

LONDON MARKET OPEN: FTSE 100 down, Reeves fails to lift mood

13th Jan 2025 09:03

(Alliance News) - Stock prices in London opened in the red on Monday, after Friday's US jobs data increased expectations of a pause in rate cuts this year. Read More

LONDON BRIEFING: Stocks red, China exports surge before Trump tariffs

13th Jan 2025 07:48

(Alliance News) - The FTSE 100 was called lower on Monday, after Friday's US jobs data strengthened Federal Reserve hawks' hand and made rate cuts less likely. Read More

GSK awaits FDA review of new shingles vaccine presentation

10th Jan 2025 08:58

(Alliance News) - GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. Read More

GSK hails FDA breakthrough therapy designation for bone cancer drug

7th Jan 2025 09:12

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer. Read More

LONDON BRIEFING: Next ups guidance after strong Christmas trade

7th Jan 2025 07:52

(Alliance News) - Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Read More

GSK treatment approved for adults with sinus condition in China

3rd Jan 2025 08:21

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study. Read More

LONDON BRIEFING: Herald Investment backs record amid Saba Capital saga

3rd Jan 2025 07:41

(Alliance News) - London's FTSE 100 is called to open slightly lower on Friday, after emerging from the new year with a hefty rise on Thursday. Read More

UK dividends calendar - next 7 days

2nd Jan 2025 12:06

Sareum served notice on commercial licence for cancer treatment

31st Dec 2024 10:50

(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum's SRA737 clinical-stage cancer treatment. Read More

GSK reports mixed findings from ovarian cancer phase III study

20th Dec 2024 08:58

(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. Read More

LONDON BRIEFING: Stocks down as UK retail sales miss forecasts

20th Dec 2024 07:52

(Alliance News) - Stocks were called lower on Friday ahead of the US Fed's preferred inflation gauge, the personal consumption expenditures reading, this afternoon. Read More

LONDON MARKET MIDDAY: Stocks red as UK consumer confidence erodes

16th Dec 2024 12:04

(Alliance News) - Stock prices in London were down at midday on Monday, while in corporate news Videndum shares fell after its trading update disappointed. Read More

GSK receives three positive regulatory updates on cancer products

16th Dec 2024 09:34

(Alliance News) - GSK PLC on Monday reported a triple dose of good news with positive regulatory updates on two leading cancer drugs. Read More

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

10th Dec 2024 10:01

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

9th Dec 2024 19:42

GSK PLC - London-based pharmaceuticals firm - Says Dreamm-7 trial shows sustained overall survival benefit for Blenrep, the brand name of belantamab mafodotin, combination versus a daratumumab combination. The data build on findings from Dreamm-7 and Dreamm-8 and supports the potential for Blenrep combinations to become standard of care. Blenrep shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse, company says. Read More

GSK's Nucala and Blenrep receive regulatory boost in US and China

9th Dec 2024 08:47

(Alliance News) - GSK PLC on Monday received a double-dose of good news with its Nucala and Blenrep products receiving positive indications from industry regulators. Read More

LONDON BRIEFING: boohoo gets ISS backing amid Frasers Group spat

9th Dec 2024 07:51

(Alliance News) - London's FTSE 100 is called higher, while stocks in Hong Kong perked up amid after a slow start amid fresh hope for the Chinese economy. Read More

FTSE 100 Latest

Value10,600.37

Change28.13